These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7198665)

  • 1. The mechanism of modulation of humoral immune responses after infection of mice with lactic dehydrogenase virus.
    Isakov N; Feldman M; Segal S
    J Immunol; 1982 Feb; 128(2):969-75. PubMed ID: 7198665
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of the immune response by a methanol-insoluble fraction of attenuated tubercle bacilli (BCG). II. Relationship of antigen dose to heightened primary and secondary immune responses to sheep red blood cells.
    Yashphe DJ
    Clin Exp Immunol; 1972 Dec; 12(4):497-506. PubMed ID: 4568152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses in mice infected with lactic dehydrogenase virus. I. Antibody response to DNP-BGG and hyperglobulinaemia in BALB/c mice.
    Michaelides MC; Simms ES
    Immunology; 1977 Jun; 32(6):981-8. PubMed ID: 885591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of an acute viral infection by a silent virus on the humoral immune responses.
    Isakov N; Feldman M; Segal S
    Adv Exp Med Biol; 1982; 149():455-60. PubMed ID: 6983226
    [No Abstract]   [Full Text] [Related]  

  • 5. T cell dependence of cells synthesizing immunoglobulin without detectable antibody function induced after an antigenic stimulation.
    Antoine JC; Petit C; Bach MA; Bach JF; Salomon JC; Avrameas S
    Eur J Immunol; 1977 Jun; 7(6):336-41. PubMed ID: 302205
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic virus infection and immune responsiveness. II. Lactic dehydrogenase virus infection and immune response to non-viral antigens.
    Oldstone MB; Tishon A; Chiller JM
    J Immunol; 1974 Jan; 112(1):370-5. PubMed ID: 4590825
    [No Abstract]   [Full Text] [Related]  

  • 7. Discontinous antibody secretion during the secondary response to sheep erythrocytes in vitro.
    Thomas DW
    J Immunol; 1974 Apr; 112(4):1602-4. PubMed ID: 4592608
    [No Abstract]   [Full Text] [Related]  

  • 8. A mechanism for the unresponsive state in BALB-c mice after repeated doses of sheep erythrocytes.
    Thomson PD; Jutila JW
    J Immunol; 1972 Oct; 109(4):742-8. PubMed ID: 4627508
    [No Abstract]   [Full Text] [Related]  

  • 9. Lactate dehydrogenase-elevating virus (LDV): lifelong coexistence of virus and LDV-specific immunity.
    van den Broek MF; Spörri R; Even C; Plagemann PG; Hänseler E; Hengartner H; Zinkernagel RM
    J Immunol; 1997 Aug; 159(4):1585-8. PubMed ID: 9257815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic control of B-cell function. I. Two genes determine the magnitude of antibody responses of inbred mice to red blood cells.
    Hetzelberger D; Eichmann K
    Immunobiology; 1982 Feb; 160(5):454-71. PubMed ID: 6175562
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection and enumeration of immunocytes producing different classes of vibriolysins after primary and secondary immunization with cholera vaccine.
    Kateley JR; Patel C; Friedman H
    J Immunol; 1974 Dec; 113(6):1815-22. PubMed ID: 4610047
    [No Abstract]   [Full Text] [Related]  

  • 12. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
    McDonald TL
    J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses in mice infected with lactic dehydrogenase virus. IV. Functional status of the macrophage during acute LDV infection.
    Michaelides MC; Simms ES
    Immunology; 1979 Feb; 36(2):241-6. PubMed ID: 86506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses in vitro. IX. Role of cell clusters.
    McIntyre JA; Pierce CW
    J Immunol; 1973 Nov; 111(5):1526-37. PubMed ID: 4583077
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary antibody formation in vitro by mouse cells in a complete homologous system.
    Munder PG; Modolell M; Raetz W; Luckenbach GA
    Eur J Immunol; 1973 Jul; 3(7):454-7. PubMed ID: 4796634
    [No Abstract]   [Full Text] [Related]  

  • 16. RFC-polar and RFC-complete cells in different phases of the primary immunologic response.
    Podkowińska I; Halasa J; Braun J; Pietrzak M; Rakowska M
    Arch Immunol Ther Exp (Warsz); 1974; 22(4):475-82. PubMed ID: 4547570
    [No Abstract]   [Full Text] [Related]  

  • 17. The immune capacity of lymphocytes after cross-linking of surface immunoglobulin receptors by antibody.
    Katz DH; Unanue ER
    J Immunol; 1972 Nov; 109(5):1022-30. PubMed ID: 5079090
    [No Abstract]   [Full Text] [Related]  

  • 18. Requirement for continuous antigenic stimulation in the development and differentiation of antibody-forming cells: effect of antigen dose.
    Hanna MG; Peters LC
    Immunology; 1971 May; 20(5):707-18. PubMed ID: 4950863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide (LPS) regulation of the immune response: LPS influence on oral tolerance induction.
    Michalek SM; Kiyono H; Wannemuehler MJ; Mosteller LM; McGhee JR
    J Immunol; 1982 May; 128(5):1992-8. PubMed ID: 6460815
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune responses to acute alphavirus infection of the central nervous system: Sindbis virus encephalitis in mice.
    Griffin DE; Mokhtarian F; Park MM; Hirsch RL
    Prog Brain Res; 1983; 59():11-21. PubMed ID: 6320262
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.